0001529224-21-000003.txt : 20210113 0001529224-21-000003.hdr.sgml : 20210113 20210113101912 ACCESSION NUMBER: 0001529224-21-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210113 DATE AS OF CHANGE: 20210113 EFFECTIVENESS DATE: 20210113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GeneCentric Therapeutics, Inc. CENTRAL INDEX KEY: 0001529224 IRS NUMBER: 452540158 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-386126 FILM NUMBER: 21525313 BUSINESS ADDRESS: STREET 1: 100 CAPITOLA DRIVE STREET 2: SUITE 275 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: (919) 973-6544 MAIL ADDRESS: STREET 1: 100 CAPITOLA DRIVE STREET 2: SUITE 275 CITY: DURHAM STATE: NC ZIP: 27713 FORMER COMPANY: FORMER CONFORMED NAME: GeneCentric Diagnostics, Inc. DATE OF NAME CHANGE: 20110902 D 1 primary_doc.xml X0708 D LIVE 0001529224 GeneCentric Therapeutics, Inc. 100 Capitola Drive Suite 275 DURHAM NC NORTH CAROLINA 27713 (919) 973-6544 DELAWARE GeneCentric Diagnostics, Inc. Corporation true Myla Lai-Goldman 100 Capitola Drive Suite 275 DURHAM NC NORTH CAROLINA 27713 Executive Officer Director Michael Milburn 100 Capitola Drive Suite 275 DURHAM NC NORTH CAROLINA 27713 Executive Officer Director Clay Thorp 100 Capitola Drive Suite 275 DURHAM NC NORTH CAROLINA 27713 Director Charles Perou 100 Capitola Drive Suite 275 DURHAM NC NORTH CAROLINA 27713 Executive Officer Director Arnold Levine 100 Capitola Drive Suite 275 DURHAM NC NORTH CAROLINA 27713 Director Ellen Lubman 100 Capitola Drive Suite 275 DURHAM NC NORTH CAROLINA 27713 Director Biotechnology Decline to Disclose 06b false 2020-12-29 false true false 0 1200000 1200000 0 false 4 0 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. false GeneCentric Therapeutics, Inc. /s/vMichael V. Milburn Michael V. Milburn Chief Executive Officer 2021-01-13